We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.92B
AUM Growth
+$640M
Cap. Flow
+$539M
Cap. Flow %
28.01%
Top 10 Hldgs %
29.55%
Holding
558
New
399
Increased
63
Reduced
49
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 22.56%
2 Healthcare 14%
3 Industrials 9.84%
4 Materials 7.61%
5 Utilities 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBR icon
126
KBR
KBR
$4.62B
$4.06M 0.21%
62,338
-14,107
-18% -$918K
COGT icon
127
Cogent Biosciences
COGT
$6.65B
$3.99M 0.21%
369,763
+43,693
+13% +$425K
AAPL icon
128
Apple
AAPL
$4.54T
$3.96M 0.21%
17,000
-97,000
-85% -$21.7M
LPLA icon
129
LPL Financial
LPLA
$28.3B
$3.88M 0.2%
+16,666
New +$3.76M
VMC icon
130
Vulcan Materials
VMC
$34.8B
$3.78M 0.2%
+15,095
New +$3.75M
AES icon
131
AES
AES
$10.5B
$3.7M 0.19%
184,235
+18,280
+11% +$323K
MDU icon
132
MDU Resources
MDU
$4.17B
$3.64M 0.19%
+239,809
New +$3.41M
IR icon
133
Ingersoll Rand
IR
$32.6B
$3.6M 0.19%
+36,675
New +$3.41M
VERA icon
134
Vera Therapeutics
VERA
$2.3B
$3.59M 0.19%
81,315
+17,765
+28% +$674K
FROG icon
135
JFrog
FROG
$9.66B
$3.54M 0.18%
122,072
+66,018
+118% +$2.07M
KNX icon
136
Knight Transportation
KNX
$11.3B
$3.54M 0.18%
+65,657
New +$3.4M
WK icon
137
Workiva
WK
$3.36B
$3.48M 0.18%
+43,954
New +$3.3M
VRDN icon
138
Viridian Therapeutics
VRDN
$2.09B
$3.47M 0.18%
+152,542
New +$2.49M
GILD icon
139
Gilead Sciences
GILD
$162B
$3.43M 0.18%
+40,904
New +$3.12M
OKTA icon
140
Okta
OKTA
$24.7B
$3.4M 0.18%
45,701
-37,011
-45% -$3.23M
ACN icon
141
Accenture
ACN
$102B
$3.33M 0.17%
+9,427
New +$3.1M
ALE
142
DELISTED
Allete
ALE
$3.32M 0.17%
51,711
BF.B icon
143
Brown-Forman Class B
BF.B
$13.2B
$3.31M 0.17%
+67,372
New +$3.03M
DOCU
144
DocuSign
DOCU
$10.5B
$3.29M 0.17%
52,933
-44,809
-46% -$2.51M
LEN icon
145
Lennar Class A
LEN
$19.8B
$3.28M 0.17%
+18,048
New +$3.02M
CTSH icon
146
Cognizant
CTSH
$24.9B
$3.18M 0.17%
+41,265
New +$3.07M
A icon
147
Agilent Technologies
A
$39.1B
$3.11M 0.16%
+20,948
New +$2.87M
INTU icon
148
Intuit
INTU
$86.5B
$3.08M 0.16%
+4,960
New +$3.17M
GEF icon
149
Greif
GEF
$4.92B
$3.06M 0.16%
48,824
-46,168
-49% -$2.83M
EXC icon
150
Exelon
EXC
$47.2B
$3.04M 0.16%
+75,000
New +$2.82M

Similar funds

Crestline Management's Q3 2024 Portfolio in Review

As of Q3 2024, Crestline Management held 558 positions worth $1.92B, up 50% from $1.28B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Crestline Management deployed $539M of net new capital in Q3 2024, opening 399 new positions and adding to 63 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 245,000 shares worth $141M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Apple, an estimated $21.7M trimmed.

  • Crestline Management's largest Q3 2024 buy was State Street SPDR S&P 500 ETF Trust: 245,000 shares worth $141M.
  • Crestline Management added most to Salesforce in Q3 2024, an estimated $22.3M increase.
  • Crestline Management's biggest Q3 2024 reduction was Apple, cutting an estimated $21.7M.
  • Crestline Management fully exited iShares Core S&P 500 ETF in Q3 2024, selling an estimated $183M.
  • Crestline Management's ten largest holdings make up 30% of its $1.92B portfolio in Q3 2024.
  • Crestline Management opened 399 new positions and closed 44 in Q3 2024.
  • Crestline Management's portfolio value rose 50% quarter-over-quarter to $1.92B.

Based on Crestline Management's 13F filing for Q3 2024, filed 13 Nov 2024.